Shanghai Hile Bio-Technology Co., Ltd. (603718.SS)
CNY 7.45
(0.0%)
CNY 7.45
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.36 Million | 292.9 Million | 43.63 Million | 167.68 Million | 59.25 Million | 18.91 Million |
| Net Income | 50.01 Million | 110.69 Million | 45.66 Million | -32.15 Million | -26.4 Million | -13.7 Million |
| Depreciation & Amortization | 39.7 Million | 47.37 Million | 57.56 Million | 58.21 Million | 57.65 Million | 53.79 Million |
| Deferred income taxes | -6.05 Million | -4.75 Million | 489.11 Thousand | -116.2 Thousand | 23.04 Million | 3.15 Million |
| Stock-based compensation | 23.29 Million | - | - | - | - | - |
| Change in working capital | -51.78 Million | 133.55 Million | -43.76 Million | 127.97 Million | 27.8 Million | -11.93 Million |
| Other non-cash items | 6.54 Million | 1.28 Million | -15.83 Million | 13.63 Million | 197.02 Thousand | -9.22 Million |
| Investing Cash Flow | -171.08 Million | 66.13 Million | 41.53 Million | -225.84 Million | -68.95 Million | -104.31 Million |
| Investments in PPE | -7.81 Million | -19.84 Million | -37.77 Million | -34.12 Million | -39.02 Million | -112.29 Million |
| Acquisitions | 108.69 Million | 148.47 Thousand | 28.2 Million | -42 Million | -58 Million | -163.76 Million |
| Investment purchases | -961.33 Million | -883.36 Million | -1.97 Billion | -2.34 Billion | -1.83 Billion | -1.37 Billion |
| Sales/Maturities of investments | 689.27 Million | 969.19 Million | 2.06 Billion | 2.19 Billion | 1.86 Billion | 1.55 Billion |
| Other Investing Activities | -160.98 Million | 0.15 | -31.49 Million | 3.1 Million | 272.34 Thousand | 248 Thousand |
| Financing Cash Flow | 159.99 Million | -355.53 Million | 50 Million | 25.04 Million | 13.65 Million | 36.14 Million |
| Debt repayment | -133.52 Million | -368.32 Million | -23.81 Million | -22.79 Million | -50 Million | -179.95 Million |
| Dividends payments | -36.51 Million | -683.93 Thousand | -2.7 Million | -3.86 Million | -6.44 Million | -39.79 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 64.36 Million | 13.47 Million | 76.8 Million | 51.7 Million | 71.37 Million | 255.88 Million |
| Accounts receivables | 54.92 Million | 24.66 Million | -68.69 Million | 11.71 Million | -24.11 Million | 11.71 Million |
| Accounts payables | -106.41 Million | 117.42 Million | 54.75 Million | 117.94 Million | 15.13 Million | -21.08 Million |
| Inventory | 5.76 Million | -3.78 Million | -30.31 Million | -1.55 Million | 13.73 Million | -5.73 Million |
| Other working capital | -112.46 Million | -4.75 Million | 489.11 Thousand | -116.2 Thousand | 23.04 Million | -6.2 Million |
| Cash at beginning of period | 156.55 Million | 153.03 Million | 17.85 Million | 50.99 Million | 46.87 Million | 96.12 Million |
| Cash at end of period | 137.09 Million | 156.55 Million | 153.03 Million | 17.85 Million | 50.99 Million | 46.87 Million |
| Capital Expenditure | -7.81 Million | -19.84 Million | -37.77 Million | -34.12 Million | -39.02 Million | -112.29 Million |
| Effect of forex changes on cash | 4619.06 | 14.83 Thousand | -47.90 | -17.49 Thousand | 155.91 Thousand | 2298.80 |
| Net cash flow / Change in cash | -19.45 Million | 3.51 Million | 135.18 Million | -33.13 Million | 4.11 Million | -49.24 Million |
| Free Cash Flow | -16.17 Million | 273.05 Million | 5.85 Million | 133.56 Million | 20.22 Million | -93.37 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.04 Million | 18.84 Million | -3.71 Million | -11.82 Million | 50.01 Million | 30.01 Million |
| Depreciation & Amortization | - | 9.6 Million | 9.6 Million | 39.7 Million | 39.7 Million | -21.31 Million |
| Deferred income taxes | - | - | - | - | -6.05 Million | - |
| Stock-based compensation | - | - | - | 23.29 Million | 23.29 Million | - |
| Change in working capital | - | -10.03 Million | - | 60.68 Million | -51.78 Million | -21.33 Million |
| Other non-cash items | 7.86 Million | 3.94 Million | 2.48 Million | -39.49 Million | 6.54 Million | -507.24 Thousand |
| Investing Cash Flow | 38.47 Million | -8.39 Million | -68.81 Million | -67.64 Million | -171.08 Million | -164.15 Million |
| Investments in PPE | -551.97 Thousand | -1.53 Million | -4.85 Million | 72.61 Thousand | -7.81 Million | -3.03 Million |
| Acquisitions | - | - | - | -6.6 Million | 108.69 Million | 1 Million |
| Investment purchases | -271 Million | -102 Million | -215 Million | -140 Million | -961.33 Million | -406.23 Million |
| Sales/Maturities of investments | 310.03 Million | 95.14 Million | 151.04 Million | 84.55 Million | 689.27 Million | 244.08 Million |
| Other Investing Activities | - | -6.85 Million | -63.95 Million | -65.42 Million | -160.98 Million | 24 Thousand |
| Financing Cash Flow | -6.03 Million | -28.95 Million | -10.43 Million | -6.63 Million | 159.99 Million | 39.92 Million |
| Debt repayment | -13.41 Million | -28.5 Million | -10 Million | -3.5 Million | -133.52 Million | -10 Million |
| Dividends payments | - | -451.31 Thousand | -434.99 Thousand | -1.06 Million | -36.51 Million | -36.51 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -19.44 Million | -451.31 Thousand | -434.99 Thousand | -2.07 Million | 64.36 Million | 86.44 Million |
| Accounts receivables | - | -10.05 Million | - | 54.92 Million | 54.92 Million | 4.17 Million |
| Accounts payables | - | - | - | - | -106.41 Million | - |
| Inventory | - | 15.74 Thousand | - | 5.76 Million | 5.76 Million | -25.5 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 37.2 Million | 56.61 Million | 137.09 Million | 162.3 Million | 156.55 Million | 299.67 Million |
| Cash at end of period | 77.52 Million | 32.17 Million | 56.61 Million | 137.09 Million | 137.09 Million | 162.3 Million |
| Capital Expenditure | -551.97 Thousand | -1.53 Million | -4.85 Million | 72.61 Thousand | -7.81 Million | -3.03 Million |
| Effect of forex changes on cash | - | 2336.35 | 684.15 | -2068.39 | 4619.06 | -1896.71 |
| Net cash flow / Change in cash | 40.31 Million | -24.44 Million | -80.47 Million | -25.21 Million | -19.45 Million | -137.37 Million |
| Free Cash Flow | 12.36 Million | 11.64 Million | -6.08 Million | 49.14 Million | -16.17 Million | -16.17 Million |
6240
ASUR
301151
KREBSBIO
VRSRF
GREAVESCOT